Issue 1384: September 12, 2018


TOP STORIES


IAC HANDOUTS


VACCINE INFORMATION STATEMENTS


OFFICIAL RELEASES AND ANNOUNCEMENTS


WORLD NEWS


FEATURED RESOURCES


EDUCATION AND TRAINING


CONFERENCES AND MEETINGS

 


TOP STORIES


CDC offers guidance to travelers as influenza season nears

On September 7, CDC released a media statement titled CDC guidance to travelers as influenza season nears. The complete release is reprinted below.

Reports in the news media of airline passengers with influenza are a reminder that the influenza season in the United States is fast approaching, and people who are sick should protect themselves—and others—by not traveling.

CDC recommends everyone six months and older get a seasonal flu vaccine, preferably by the end of October. Most people with the flu have mild illness and don’t need medical care or antiviral drugs. If you get sick with flu symptoms—fever, cough, sore throat, runny/stuff nose, body aches, headaches, chills, fatigue, and sometimes diarrhea and vomiting—stay home, don’t travel, and avoid contact with other people except to get medical care.

However, if you have symptoms of flu and are in a high-risk group (such as children younger than 5, adults 65 and older, pregnant women, residents of nursing home or long-term care facilities, American Indians and Alaska Natives, and people who have certain medical conditions), or are very sick or worried about your illness, contact your health care provider (doctor, physician assistant, nurse).

When you talk to your health care provider about upcoming travel, ask about routine vaccines that are right for you. In addition to getting any recommended travel vaccines, make sure you and your family are up to date on all routine vaccines, such as MMR vaccine, before you travel.

For more information on seasonal influenza, visit www.cdc.gov/flu.


Back to top


Register now! Dr. Sharon G. Humiston, IAC's associate director for research, will present a webinar on adolescent immunization and the 16-year-old platform on September 26

Sharon G. Humiston, MD, MPH, FAAP, IAC's associate director for research, will present a one-hour webinar titled "Adolescent Immunization Update and the 16-Year-Old Platform" on September 26, at 1:00 p.m. (ET). During her presentation, Dr. Humiston will review the recommendations for adolescent vaccines, including those recommended at 11–12 years of age and those at age 16.

CDC's most recent National Immunization Survey, published on August 24, found that 51% of adolescents had not completed the HPV vaccine series, and 56% had not received both doses of MenACWY vaccine. In addition, fewer adolescents in rural areas, compared with those in urban areas, are getting these vaccines.

Register today for the webinar.

Related Links

Back to top


AAP publishes its vaccination recommendations for 2018–19 influenza season

The American Academy of Pediatrics (AAP) published Recommendations for Prevention and Control of Influenza in Children, 2018–2019 online on September 3. These recommendations will also be published in the October issue of Pediatrics.

Read the recommendations: Recommendations for Prevention and Control of Influenza in Children, 2018–2019 in PDF format.

Read a related article from the AAP News: AAP policy emphasizes importance of vaccination after high-severity flu season.

On August 24, CDC published Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season in MMWR.

Back to top



IAC Spotlight! The Vaccine Manufacturers web page on immunize.org provides company contact information and more

The Vaccine Manufacturers web page on IAC's website, immunize.org, provides links to the websites of the nine vaccine manufacturers in the United States, as well as contact information such as phone numbers and several email addresses. In addition, the vaccine products for each of the companies are listed.

Visit the Vaccine Manufacturers web page on immunize.org.

Related Link

Back to top


IAC HANDOUTS


IAC updates its popular "Summary of Recommendations for Child/Teen Immunization" and "Summary of Recommendations for Adult Immunization"

IAC recently updated its popular 5-page immunization guidance documents for healthcare professionals: "Summary of Recommendations for Child/Teen Immunization" and "Summary of Recommendations for Adult Immunization."

Summary of Recommendations for Child/Teen Immunization: Changes were made to delete several precautions for receipt of DTaP consistent with ACIP's 2018 recommendations and the DTaP Vaccine Information Statement, dated 8/24/2018  (i.e., seizure within 3 days, pale or limp episode or collapse within 48 hours, continuous crying for 3 or more hours within 48 hours, and/or fever of 105F within 48 hours of a previous dose), to add Heplisav-B as a hepatitis B vaccine option for teens age 18 years and older, and to add live attenuated influenza vaccine (LAIV) as a vaccine option for the 2018–19 influenza vaccination season.

Summary of Recommendations for Adult Immunization: Revisions were made to incorporate recommendations for the use of live attenuated influenza vaccine (LAIV) for the 2018–19 influenza vaccination season. Heplisav-B was added as an option for hepatitis B vaccination previously.

The child/teen piece covers age birth through age 18 years, while the adult piece covers age 19 years and older. Both include columns for vaccine name/route, routine schedule and guidelines, schedule for catch-up and related issues, and contraindications and precautions.

Related Link

IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.

Back to top


IAC posts revised standing orders templates for influenza vaccination of adults and children/teens

IAC recently revised both its standing orders templates for administering influenza vaccine: one for children and teens and the other for adults. The same changes were made to both the adult and child/teen versions: removing the “Note” that stated ACIP did not recommend use of LAIV for the current vaccination season, inserting an additional antiviral (peramivir) for which vaccination would be contraindicated if given within the previous 48 hours, and deleting all references to the IIV intradermal vaccine (Fluzone Intradermal) which is no longer available.

Related Link

  • IAC's Standing Orders web section contains standing orders templates for administering all routinely recommended vaccines and for the medical management of vaccine reactions

Back to top


IAC updates "Guide to Contraindications and Precautions to Commonly Used Vaccines" and "Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults"

IAC recently revised the 2-page "Guide to Contraindications and Precautions to Commonly Used Vaccines" and 1-page "Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults." The 2-page guide covers both children and adults.

Guide to Contraindications and Precautions to Commonly Used Vaccines: Changes were made to the second page only, which includes the guidance for healthcare professionals. Changes include the deletion of several precautions for receipt of DTaP, consistent with ACIP's 2018 recommendations and the DTaP Vaccine Information Statement, dated 8/24/2018  (i.e., seizure within 3 days, pale or limp episode or collapse within 48 hours, continuous crying for 3 or more hours within 48 hours, and/or fever of 105F within 48 hours of a previous dose) and the addition of the live attenuated influenza vaccine (LAIV) as a vaccine option for the 2018–19 influenza vaccination season.

Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults: Revisions were made to incorporate recommendations for the use of live attenuated influenza vaccine (LAIV) for the 2018–19 influenza vaccination season.

Back to top


IAC posts revised "Screening Checklist for Contraindications to Vaccines for Children and Teens" and "Screening Checklist for Contraindications to Vaccines for Adults"

IAC recently revised "Screening Checklist for Contraindications to Vaccines for Children and Teens" and "Screening Checklist for Contraindications to Vaccines for Adults."

Screening Checklist for Contraindications to Vaccines for Children and Teens: Revisions were made to the second page only, which is the guidance for the use of the checklist by healthcare professionals. Changes were made to remove the “Note” that stated ACIP did not recommend use of live attenuated influenza vaccine (LAIV) for the current vaccination season, to delete several precautions for receipt of DTaP, consistent with ACIP's 2018 recommendations and the DTaP Vaccine Information Statement, dated 8/24/2018  (i.e., seizure within 3 days, pale or limp episode or collapse within 48 hours, continuous crying for 3 or more hours within 48 hours, and/or fever of 105F within 48 hours of a previous dose), and to clarify the degree of immunosuppression for HIV-infected children who may be candidates for varicella vaccine.

Screening Checklist for Contraindications to Vaccines for Adults: Revisions were made to the second page only, which is the guidance for the use of the checklist by healthcare professionals. Revisions were made to add LAIV as an option for influenza vaccines available to people with egg allergy and other minor edits in references.

Access IAC's Screening Checklists web page.

Back to top


IAC posts "Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months Through 8 Years"

IAC recently posted Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months Through 8 Years. Changes were made to convert this 1-page guide to a more general algorithm since the guidance no longer changes from season to season.

Access all IAC influenza educational materials for healthcare professionals and patients.

Back to top


IAC updates "Influenza Vaccination of People with a History of Egg Allergy"

IAC has updated Influenza Vaccination of People with a History of Egg Allergy to include live attenuated influenza vaccine (LAIV) as one of the influenza vaccines appropriate for vaccination of persons with egg allergy.

Access all IAC influenza educational materials for healthcare professionals and patients.

Back to top


VACCINE INFORMATION STATEMENTS


IAC posts new German-language translation of the Inactivated Influenza Vaccine VIS

IAC recently posted a German-language translation of the Inactivated Influenza Vaccine (IIV) VIS. This is a new translation donated by Landstuhal Regional Medical Center, Germany.

Related Links

Visit IAC's VIS web section for VISs in up to 50 languages

Back to top


OFFICIAL RELEASES AND ANNOUNCEMENTS


WHO issues updated position paper on dengue vaccine

WHO published Dengue vaccine: WHO position paper—September 2018 in the September 7 issue of its Weekly Epidemiological Record. This is the most recent addition to a WHO-issued series of regularly updated position papers on vaccines that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programs.

Related Links

Back to top


WORLD NEWS


Campaign launched to vaccinate almost 14 million children in Afghanistan against measles

On September 1, the World Health Organization (WHO) published an article titled Nearly 14 million children in Afghanistan to be immunized against measles following a growing increase in number of reported cases. Selections from the article are reprinted below.

The Government of Afghanistan, in collaboration with the United Nations Children’s Fund (UNICEF), the World Health Organization (WHO) and Gavi, the Vaccine Alliance, have today launched a nationwide vaccination campaign to protect 13.8 million children aged 9 months to 10 years against measles....

Measles is one of the most contagious infections known to humans, and ranks among the top 4 childhood killers worldwide. In Afghanistan, of the 25,000 reported cases in 2017, 85% are among children under the age of 10. This spans over 20 of the 34 provinces across Afghanistan, with the worst affected provinces being Kabul, Paktika, Kunar, Badghis, and Ghor....

The measles vaccine will be administered free of charge in all mosques, villages, and health facilities throughout the country, targeting all children under the age of 10, irrespective of their previous measles vaccination status or history of disease....


Read the complete article: Nearly 14 million children in Afghanistan to be immunized against measles following a growing increase in number of reported cases.

Back to top



CDC reports on progress toward polio containment worldwide

CDC published Progress Toward Poliovirus Containment Implementation—Worldwide, 2017–2018 in the September 7 issue of MMWR (pages 992–995). Sections of the first paragraph are reprinted below.

Substantial progress has been made since the World Health Assembly (WHA) resolved to eradicate poliomyelitis in 1988. Among the three wild poliovirus (WPV) types, type 2 (WPV2) was declared eradicated in 2015, and type 3 (WPV3) has not been reported since 2012. In 2017 and 2018, only Afghanistan and Pakistan have reported WPV type 1 (WPV1) transmission. When global eradication of poliomyelitis is achieved, facilities retaining poliovirus materials need to minimize the risk for reintroduction of poliovirus into communities and reestablishment of transmission.... As of August 2018, 29 countries had designated 81 facilities to retain PV2 materials; 22 of these countries had established NACs. Although there has been substantial progress, intensification of containment measures is needed.

Related Link

  • MMWR main page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements

Back to top



FEATURED RESOURCES


Still available! IAC's sturdy laminated version of the 2018 U.S. adult immunization schedule—order a supply for your healthcare setting today! Child/teen schedules sold out.

IAC's laminated versions of the 2018 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. The schedule is eight pages (i.e., four double-sided pages) and is folded to measure 8.5" x 11". 

The child/teen immunization schedules are sold out. If you wish to order a quantity of 500 or more, you can email admininfo@immunize.org to request a quote.                           

Adult Laminated Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org.

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top


IAC's 142-page book, Vaccinating Adults: A Step-by-Step Guide, describes how to implement adult vaccination services in your healthcare setting and provides a review for staff who already vaccinate adults; IAC Guide available for free download

In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide).



This completely updated guide on adult immunization (originally published in 2004) provides easy-to-use, practical information covering important “how-to” activities to help providers enhance their existing adult immunization services or introduce them into any clinical setting, including:

  • setting up for vaccination services,
  • storing and handling vaccines,
  • deciding which people should receive which vaccines,
  • administering vaccines,
  • documenting vaccinations (including legal issues), and
  • understanding financial considerations and billing information.

In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.

The entire Guide is available to download/print free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. Options are available online to download the entire book or selected chapters. The development of the Guide was supported by the National Vaccine Program Office (NVPO) and the Centers for Disease Control and Prevention (CDC). Expert staff from both agencies also provided early technical review of the content.

The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!

Related Links

Back to top


EDUCATION AND TRAINING


VICNetwork webinar, "2018–19 Seasonal Flu Recommendations and Communications Messaging," scheduled for September 17

On September 17 at 1:00 p.m. (ET) the California Immunization Coalition's VICNetwork will sponsor a webinar titled "2018–19 Seasonal Flu Recommendations and Communications Messaging."

Registration information

The VICNetwork is a nationwide "virtual immunization community" of health educators, public health communicators, and others who promote immunizations to exchange and share resources, materials, and the best practices.

Back to top


Center for HIV Law and Policy, Harm Reduction Coalition, and the National Viral Hepatitis Roundtable will host an October 4 webinar about the relationship between criminalization, viral hepatitis, and harm reduction 

On October 4 at 3:00 p.m. (ET), the Center for HIV Law and Policy, Harm Reduction Coalition, and the National Viral Hepatitis Roundtable will host a webinar that will provide an overview of the relationship between criminalization, viral hepatitis, and harm reduction. Attendees will learn about harm reduction principles, current trends in syringe service programs and treatment access for viral hepatitis, and efforts to reform laws criminalizing HIV and viral hepatitis. The webinar will include substantial time for audience Q&A with presenters.

Access registration information for "Punishment Is Not a Public Health Strategy: The Criminalization of Viral Hepatitis in the United States."

Back to top


Weekly CDC webinar series on "The Pink Book" chapter topics continues September 19 with "Pneumococcal Vaccines"; register now for series running through September 26

CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (also known as "The Pink Book"). This is a live series of weekly 1-hour webinars that started June 6 and will run through September 26. The webinar series provides an overview of vaccines and the diseases they prevent, general recommendations for vaccines, vaccination principles, and immunization strategies for providers.
 
The September 19 webinar will cover "Pneumococcal Vaccines" and include a live Q&A session. Recordings of sessions will be available online within 2 weeks after each webinar. All sessions begin at 12:00 p.m. (ET). Free continuing education is available for healthcare personnel including physicians, nurses, nurse practitioners, pharmacists, physician’s assistants, and others.

Registration and more information is available on CDC's Pink Book Webinar Series web page.

All the sections of "The Pink Book" (i.e., chapters, appendices, 2017 supplement) are available to download at no charge at www.cdc.gov/vaccines/pubs/pinkbook/index.html.

You can also order this resource from the Public Health Foundation for $40 plus shipping and handling. 


CDC updates "You Call the Shots" modules on zoster and vaccine administration; free CE credit available

CDC updated the Vaccine Administration and Zoster modules of its web-based training course "You Call the Shots," a program for all immunization providers. The program includes 18 modules on immunization topics (e.g., DTaP, Hepatitis A, Influenza, Vaccine Storage and Handling, and Vaccines for Children).

Continuing education (CE) credit is available for a variety of healthcare professionals by viewing a module and completing an evaluation. 

Participants can access information about obtaining CE credit from the You Call the Shots main page.

Related Link

Back to top


NFID Clinical Vaccinology Course scheduled for November 9–10 in Bethesda

The National Foundation of Infectious Disease's (NFID) Fall 2018 Clinical Vaccinology Course will be held November 9–10 in Bethesda, MD. This 2-day course focuses on new developments and issues related to the use of vaccines. Expert faculty will provide the latest information on vaccines, including updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate immunization.

Continuing education credit is available for attendees. Register by September 27 to receive the early registration rate. 

Back to top
 


State of Michigan's 2018 fall regional immunization conferences to take place in eight cities on different dates

Registration is now open for the state of Michigan's 2018 fall immunization conferences to be held in Marquette (October 9), Gaylord (October 11), Grand Rapids (October 30), Kalamazoo (November 1), Flint (November 2), Lansing (November 13), Dearborn (November 15), and Troy (November 16).

These 1-day conferences will provide participants with a variety of practice-management tools, techniques, and information that will help assure that all of their patients are fully immunized. The conferences are appropriate for physicians, nurses, nurse practitioners, medical assistants, public health staff, pharmacists, physicians, physician assistants, and medical and nursing students.

Registration information

Back to top


Presentation slides from June ACIP meeting are now available; next meeting scheduled for October 24–25

ACIP recently posted the presentation slides from the ACIP meeting held June 21–22.

ACIP will hold its next meeting on October 24–25  in Atlanta. To attend the meeting, ACIP attendees (participants and visitors) must register online. The registration deadline for non-U.S. citizens is September 26; for U.S. citizens, it's October 10. Registration is not required to watch the meeting via webcast or listen to the proceedings via phone. See the first link below for the toll-free phone number and passcode.

Related Links

Back to top

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.

If you have trouble receiving or displaying IAC Express messages, visit our online help section.

IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.

IAC Express Disclaimer
ISSN: 1526-1786
Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2018 Immunization Action Coalition
All rights reserved.

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .